Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOC1 anticorps (AA 35-48)

Cet anticorps Lapin Polyclonal détecte spécifiquement APOC1 dans IHC et ELISA. Il présente une réactivité envers Humain.
N° du produit ABIN7144415

Aperçu rapide pour APOC1 anticorps (AA 35-48) (ABIN7144415)

Antigène

Voir toutes APOC1 Anticorps
APOC1 (Apolipoprotein C-I (APOC1))

Reactivité

  • 51
  • 5
  • 4
  • 4
  • 3
  • 1
  • 1
Humain

Hôte

  • 46
  • 11
  • 9
  • 2
Lapin

Clonalité

  • 54
  • 14
Polyclonal

Conjugué

  • 44
  • 6
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp APOC1 est non-conjugé

Application

  • 46
  • 39
  • 27
  • 24
  • 15
  • 9
  • 5
  • 5
  • 2
  • 2
  • 2
  • 1
Immunohistochemistry (IHC), ELISA
  • Épitope

    • 7
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    AA 35-48

     Réactivité croisée

    Humain

    Purification

    >95%, Protein G purified

    Immunogène

    Recombinant Human Apolipoprotein C-I protein (35-48aa)

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: IHC:1:100-1:500,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    APOC1 (Apolipoprotein C-I (APOC1))

    Autre désignation

    APOC1

    Sujet

    Background: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

    Aliases: Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I], APOC1

    UniProt

    P02654

    Pathways

    Apoptose
Vous êtes ici:
Chat with us!